no statement of use filed
on 24 Mar 2020
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
87128871 filed on 05th Aug 2016
Registration Number
N/A
Correspondent Address
CAMILLE M. MILLER
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"CANCER"
Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pRead More
Development and testing services in the fields of biotechnology, chemistry and pharmaceuticals; scientific study and research in the fields of the prevention, treatment and management of illness, health care delivery and the scientific aspects of health care policy, health care cost management and financing as these fields impact on quality of health care; research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; providing clinical laboratory testing services for medical and scientific research and development purposes, namely, pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries; scientific research services; scientific research, namely, development of pharmaceuticals or diagnostic methods for others
Providing on-line information in the field of diagnosis and treatment of cancer; providing an on-line computer database featuring information relating to diagnosis and treatment of cancer; providing medical and pharmaceutical information services; providing links to web sites of others featuring information about the diagnosis and treatment of cancer; providing medical information and pharmaceutical information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; health care services, namely, disease management programs that provide counseling and information in the field of pharmaceuticals, and distributing written materials in connection therewith; providing an interactive website featuring medical information that enables users to enter, access, track, monitor and generate health and medical information and reports; providing pharmacogenetic testing, predictive medical testing, personalized medical testing, gene sequencing-based testing and genotyping, all for medical diagnostic and treatment purposes, based on the assessment, development and application of genomic discoveries in the pharmaceutical, informatics and clinical diagnostic industries
Pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of certain blood diseases and cancers
Providing information concerning consumer product safety via government pharmaceutical programs that provide counseling and information to medical professionals, pharmacists and patients, particularly counseling and information on consumer product safety issues pertaining to pharmaceuticals, and distributing printed materials in connection therewith
No 87128871
No Service Mark
No 333849/CELG-
No
No
No
No
No
No
No
No
01.07.01 -
Globes with outlines of continents
24.17.16 -
Universal prohibition symbol
The mark consists of a red universal prohibition symbol with a blue and white globe inside and the word "CANCER" in white with a red line diagonally through it, all above a gray shadow.
Status Date | Action Taken |
---|---|
28th May 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
28th May 2020 | ABANDONMENT - NO USE STATEMENT FILED |
24th Aug 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
23rd Aug 2019 | EXTENSION 5 GRANTED |
22nd Aug 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
19th Aug 2019 | TEAS EXTENSION RECEIVED |
19th Aug 2019 | EXTENSION 5 FILED |
24th Jan 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
22nd Jan 2019 | EXTENSION 4 GRANTED |
22nd Jan 2019 | EXTENSION 4 FILED |